Abstract
We examined 134 pediatric clinical isolates of Enterobacteriaceae, Pseudomonas aeruginosa, and gram-positive cocci for susceptibility to aztreonam alone and in combination with seven other antibiotics. All 98 gram-negative isolates were susceptible to aztreonam with similar inhibitory and bactericidal activity. Combinations of aztreonam with cefoxitin, ampicillin, or clindamycin were generally indifferent or additive. Synergism was occasionally seen against enteric organisms with aztreonam plus cefoxitin or clindamycin. Combinations of tobramycin and aztreonam were synergistic (62%) against P. aeruginosa; aztreonam plus piperacillin or ticarcillin was additive. Aztreonam did not affect the activity of nafcillin against Staphylococcus aureus, or of ampicillin against species of Streptococcus group B or D. Antagonism was seen only with aztreonam plus cefoxitin against Enterobacter species, but not at clinically significant concentrations. Several combinations of antibiotics with aztreonam should be appropriate for initial therapy of infections in children without major risks of antibacterial antagonism.
References
Jun 1, 1979·Antimicrobial Agents and Chemotherapy·C C Sanders, W E Sanders
Jun 1, 1975·Antimicrobial Agents and Chemotherapy·J MichelT Sacks
Apr 1, 1983·The Journal of Infectious Diseases·T C King, D J Krogstad
Jul 1, 1983·Reviews of Infectious Diseases·C C Sanders, W E Sanders
Jul 1, 1983·Antimicrobial Agents and Chemotherapy·C C SandersR V Goering
Mar 1, 1983·The Journal of Infectious Diseases·C C Sanders
Dec 1, 1981·The Journal of Antimicrobial Chemotherapy·D S ReevesH A Holt
Jan 1, 1983·Chemotherapy·S M Markowitz, D J Sibilla
Nov 1, 1982·Antimicrobial Agents and Chemotherapy·N V JacobusM Barza
Feb 1, 1982·Antimicrobial Agents and Chemotherapy·V FainsteinG P Bodey
Jan 1, 1982·Antimicrobial Agents and Chemotherapy·R B SykesN H Georgopapadakou
Jun 11, 1981·Nature·R B SykesJ S Wells
May 1, 1981·Reviews of Infectious Diseases·T C KingD J Krogstad
Dec 1, 1981·The Journal of Antimicrobial Chemotherapy·E A SwabbA A Sugerman
Citations
Aug 1, 1997·Journal of the American Academy of Dermatology·M E EpsteinN S Sadick
Jan 25, 2013·The Journal of Antimicrobial Chemotherapy·Beatrice HoferMalcolm G P Page
Aug 1, 1985·Antimicrobial Agents and Chemotherapy·J Romero-VivasM García de la Torre
Nov 1, 1991·Mayo Clinic Proceedings·N S Brewer, W C Hellinger
Apr 30, 1999·Mayo Clinic Proceedings·W C Hellinger, N S Brewer
Sep 15, 2015·Nature Chemical Biology·Patrick R GonzalesGautam Dantas
Aug 1, 1986·The American Journal of Medicine·P G JonesG P Bodey
Sep 1, 1986·Pediatric Pulmonology·M D ReedJ L Blumer
Jan 13, 2001·Dermatologic Clinics·N S Sadick
Feb 8, 1985·The American Journal of Medicine·R B Sykes, D P Bonner
Feb 8, 1985·The American Journal of Medicine·J D Allan, R C Moellering
Oct 14, 2014·Diagnostic Microbiology and Infectious Disease·Christine RahmeThomas P Lodise
Feb 25, 1988·The New England Journal of Medicine·G R Donowitz, G L Mandell
Feb 20, 2020·Biomaterials Science·Avinash Yashwant GahaneAshwani Kumar Thakur
Sep 1, 1991·DICP : the Annals of Pharmacotherapy·A W Hopefl
Jan 1, 1987·Infection·P Dejace, J Klastersky